INVA Q3 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M+46.0% YoY

Gross Profit

$48M99.4% margin

Operating Income

$40M82.3% margin

Net Income

$24M48.9% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

-16.9%

Cash Flow

Operating Cash Flow

$43M

Free Cash Flow

$43M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$391M

Total Liabilities

$614M

Stockholders' Equity

-$223M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$33M	+46.0%
Gross Profit	$48M	$33M	+46.4%
Operating Income	$40M	$28M	+43.4%
Net Income	$24M	$15M	+58.1%